investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes
Honami Naora
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Hao Yuan Kueh
Single cell analysis of hematopoietic cell fate determination
Leukaemia
Craig B Thompson
Role of IDH Mutations in Acute Myeloid Malignancies
Leukaemia
Catherine Ju-Ying Wu
(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL
Leukaemia
Pathology
Hematology and hematologic malignancies
Omar Abdel-Wahab
Role of ASXL1 mutations in myeloid malignancies
Leukaemia
Marina Y Konopleva
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
Leukaemia
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Neil Osheroff
Function and Biology of Eukaryotic DNA Topoisomerases
Leukaemia
Scott A Armstrong
Targeting to Epigenetic Modications in ALL
Leukaemia
Alex Kentsis
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
Leukaemia